![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 ALVIMOPAN (1)
02 CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM (1)
03 DAPTOMYCIN (3)
04 FIDAXOMICIN (2)
05 TEDIZOLID PHOSPHATE (2)
01 CAPSULE;ORAL (1)
02 FOR SUSPENSION;ORAL (1)
03 POWDER;INTRAVENOUS (5)
04 TABLET;ORAL (2)
01 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 200MG (2)
03 200MG/VIAL (1)
04 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
05 40MG/ML (1)
06 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (2)
07 EQ 1GM BASE/VIAL;EQ 0.5GM BASE/VIAL (1)
01 DISCN (4)
02 RX (5)